1. Home
  2. OGN vs GRDN Comparison

OGN vs GRDN Comparison

Compare OGN & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$8.78

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Guardian Pharmacy Services Inc.

GRDN

Guardian Pharmacy Services Inc.

HOLD

Current Price

$26.92

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
GRDN
Founded
1923
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
OGN
GRDN
Price
$8.78
$26.92
Analyst Decision
Hold
Strong Buy
Analyst Count
5
3
Target Price
$14.10
$33.33
AVG Volume (30 Days)
5.3M
291.7K
Earning Date
02-12-2026
11-10-2025
Dividend Yield
0.91%
N/A
EPS Growth
N/A
N/A
EPS
1.91
0.28
Revenue
$6,301,000,000.00
$1,389,638,000.00
Revenue This Year
N/A
$19.50
Revenue Next Year
N/A
$0.48
P/E Ratio
$4.58
$96.96
Revenue Growth
N/A
18.68
52 Week Low
$6.18
$17.78
52 Week High
$17.23
$37.43

Technical Indicators

Market Signals
Indicator
OGN
GRDN
Relative Strength Index (RSI) 75.89 32.27
Support Level $8.17 $30.17
Resistance Level $8.49 $31.90
Average True Range (ATR) 0.36 1.42
MACD 0.15 -0.38
Stochastic Oscillator 98.60 0.40

Price Performance

Historical Comparison
OGN
GRDN

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About GRDN Guardian Pharmacy Services Inc.

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

Share on Social Networks: